Zobrazeno 1 - 6
of 6
pro vyhledávání: '"D'Amico risk stratification"'
Publikováno v:
Online Journal of Health & Allied Sciences, Vol 18, Iss 4 (2020)
Prostate cancer-the most common malignancy- among men worldwide, is among ten leading cancers in Kerala. The changes in serum PSA values at different time points of treatment might be of prognostic importance. The objective of this retrospective stud
Externí odkaz:
https://doaj.org/article/509496485c2641fa83e257a524cd2bac
Autor:
Klaassen, Z, Singh, AA, Howard, LE, Feng, Z, Trock, BJ, Terris, MK, Aronson, WJ, Cooperberg, MR, Amling, CL, Kane, CJ, Partin, AWW, Han, M, Freedland, SJ
Publikováno v:
Cancer, vol 121, iss 9
Klaassen, Z; Singh, AA; Howard, LE; Feng, Z; Trock, B; Terris, MK; et al.(2015). Is clinical stage T2c prostate cancer an intermediate-or high-risk disease?. Cancer, 121(9), 1414-1421. doi: 10.1002/cncr.29147. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4qp9q97h
Klaassen, Z; Singh, AA; Howard, LE; Feng, Z; Trock, BJ; Terris, MK; et al.(2015). Is clinical stage T2c prostate cancer an intermediate-or high-risk disease?. Cancer. doi: 10.1002/cncr.29147. UCSF: Retrieved from: http://www.escholarship.org/uc/item/59b1m7tq
Klaassen, Z; Singh, AA; Howard, LE; Feng, Z; Trock, B; Terris, MK; et al.(2015). Is clinical stage T2c prostate cancer an intermediate-or high-risk disease?. Cancer, 121(9), 1414-1421. doi: 10.1002/cncr.29147. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4qp9q97h
Klaassen, Z; Singh, AA; Howard, LE; Feng, Z; Trock, BJ; Terris, MK; et al.(2015). Is clinical stage T2c prostate cancer an intermediate-or high-risk disease?. Cancer. doi: 10.1002/cncr.29147. UCSF: Retrieved from: http://www.escholarship.org/uc/item/59b1m7tq
© 2014 American Cancer Society. BACKGROUND: Clinical stage T2c (cT2c) is an indeterminate factor in prostate cancer (PC) risk stratification. According to the D'Amico grouping and American Urological Association guidelines, cT2c is a high risk, wher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ce2ef877688aaabec2782cf75cc2a682
https://escholarship.org/uc/item/59b1m7tq
https://escholarship.org/uc/item/59b1m7tq
Autor:
Stephen H. Howell, Nissi Varki, Massimo Ammirante, Michelle Muldong, Ahmed Shabaik, Amy Strasner, Christina Jamieson, Christopher J. Kane, Michael Karin, Jason Woo, Michael A. Liss, Kerrin Palazzi
Publikováno v:
Journal of Translational Medicine
Journal of translational medicine, vol 12, iss 1
Woo, JR; Liss, MA; Muldong, MT; Palazzi, K; Strasner, A; Ammirante, M; et al.(2014). Tumor infiltrating B-cells are increased in prostate cancer tissue. Journal of Translational Medicine, 12(1). doi: 10.1186/1479-5876-12-30. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/5pp7p1s9
Journal of translational medicine, vol 12, iss 1
Woo, JR; Liss, MA; Muldong, MT; Palazzi, K; Strasner, A; Ammirante, M; et al.(2014). Tumor infiltrating B-cells are increased in prostate cancer tissue. Journal of Translational Medicine, 12(1). doi: 10.1186/1479-5876-12-30. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/5pp7p1s9
Background: The presence of increased B-cell tumor infiltrating lymphocytes (TILs) was seen in mouse prostate cancer (PCa) but has not been fully documented in human PCa. We, therefore, investigated the density of infiltrating B cells within human PC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ede3a03ab6a5d507734246f3198675a
http://europepmc.org/articles/PMC3914187
http://europepmc.org/articles/PMC3914187
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.